辐射诱导的皮肤状细胞癌显示出对pembrolizumab的显著反应:一个病例报告
Manami Takahashi-Watanabe1, Taku Fujimura1, Ryo Amagai1
1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
The Journal of dermatology
|April 17, 2024
概括
患有真菌菌菌菌病 (MF) 的患者的辐射诱导皮肤癌 (cSCC) 可能对 pembrolizumab 反应良好. 这种免疫疗法为晚期辐射诱导的cSCC提供了潜在的治疗方法,即使在高风险病例中也是如此.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 皮肤状细胞癌 (cSCC) 在辐射皮肤炎中发展,具有更高的转移风险.
- 免疫抑制是一种已知的cSCC风险因素,表明真菌菌菌病 (MF) 是潜在的风险因素.
- 多发性淋巴瘤是一种影响皮肤的T细胞淋巴瘤.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
14.3K
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
